Global Precision Medicine Market Overview And Scope:
Global Precision Medicine Market Size was estimated at USD 130470 million in 2022 and is projected to reach USD 226130 million by 2028, exhibiting a CAGR of 9.6% during the forecast period.:
The Global Precision Medicine Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Precision Medicine utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux Sa, Cepheid, IBM, Qiagen, Thermo Fisher Scientific, Randox Laboratories, Almac Group, Healthcore
Impact of COVID-19 And the Russia-Ukraine War on Precision Medicine Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Precision Medicine market in 2020.
The Russia-Ukraine war has had a profound impact on the global energy landscape, causing significant disruptions to supply chains and resulting in soaring prices that have hit consumers hard. The conflict has highlighted the risks of over-reliance on fossil fuels, which are often supplied by only a handful of major producers, and underscored the need for an accelerated shift towards low-carbon energy sources such as renewables and nuclear.
Global Precision Medicine Market Segmentation
Global Precision Medicine Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Precision Medicine market has been segmented into:
Diagnostics
Therapies
By Application, Precision Medicine market has been segmented into:
Oncology
Neurosciences
Immunology
Respiratory
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Precision Medicine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Precision Medicine market.
Top Key Players Covered in Precision Medicine market are:
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
Objective to buy this Report:
1. Precision Medicine analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Precision Medicine market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Precision Medicine Market by Type
5.1 Precision Medicine Market Overview Snapshot and Growth Engine
5.2 Precision Medicine Market Overview
5.3 Diagnostics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Diagnostics: Geographic Segmentation
5.4 Therapies
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Therapies: Geographic Segmentation
Chapter 6: Precision Medicine Market by Application
6.1 Precision Medicine Market Overview Snapshot and Growth Engine
6.2 Precision Medicine Market Overview
6.3 Oncology
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Oncology: Geographic Segmentation
6.4 Neurosciences
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Neurosciences: Geographic Segmentation
6.5 Immunology
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Immunology: Geographic Segmentation
6.6 Respiratory
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Respiratory: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Precision Medicine Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Precision Medicine Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Precision Medicine Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 JOHNSON & JOHNSON
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ROCHE
7.4 LABCORP
7.5 ABBOTT LABORATORIES
7.6 NOVARTIS
7.7 ILLUMINA
7.8 GE HEALTHCARE
7.9 INTEL CORPORATION
7.10 BIOMRIEUX SA
7.11 CEPHEID
7.12 IBM
7.13 QIAGEN
7.14 THERMO FISHER SCIENTIFIC
7.15 RANDOX LABORATORIES
7.16 ALMAC GROUP
7.17 HEALTHCORE
Chapter 8: Global Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Diagnostics
8.2.2 Therapies
8.3 Historic and Forecasted Market Size By Application
8.3.1 Oncology
8.3.2 Neurosciences
8.3.3 Immunology
8.3.4 Respiratory
8.3.5 Others
Chapter 9: North America Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Diagnostics
9.4.2 Therapies
9.5 Historic and Forecasted Market Size By Application
9.5.1 Oncology
9.5.2 Neurosciences
9.5.3 Immunology
9.5.4 Respiratory
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Diagnostics
10.4.2 Therapies
10.5 Historic and Forecasted Market Size By Application
10.5.1 Oncology
10.5.2 Neurosciences
10.5.3 Immunology
10.5.4 Respiratory
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Diagnostics
11.4.2 Therapies
11.5 Historic and Forecasted Market Size By Application
11.5.1 Oncology
11.5.2 Neurosciences
11.5.3 Immunology
11.5.4 Respiratory
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Diagnostics
12.4.2 Therapies
12.5 Historic and Forecasted Market Size By Application
12.5.1 Oncology
12.5.2 Neurosciences
12.5.3 Immunology
12.5.4 Respiratory
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Diagnostics
13.4.2 Therapies
13.5 Historic and Forecasted Market Size By Application
13.5.1 Oncology
13.5.2 Neurosciences
13.5.3 Immunology
13.5.4 Respiratory
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Precision Medicine Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Diagnostics
14.4.2 Therapies
14.5 Historic and Forecasted Market Size By Application
14.5.1 Oncology
14.5.2 Neurosciences
14.5.3 Immunology
14.5.4 Respiratory
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Precision Medicine Scope:
|
Report Data
|
Precision Medicine Market
|
|
Precision Medicine Market Size in 2025
|
USD XX million
|
|
Precision Medicine CAGR 2025 - 2032
|
XX%
|
|
Precision Medicine Base Year
|
2024
|
|
Precision Medicine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux Sa, Cepheid, IBM, Qiagen, Thermo Fisher Scientific, Randox Laboratories, Almac Group, Healthcore.
|
|
Key Segments
|
By Type
Diagnostics
Therapies
By Applications
Oncology
Neurosciences
Immunology
Respiratory
Others
|
